Evidence map›Paper›PMID 41355737›Full record

ArticleACS applied materials & interfaces2025

Injectable Nanocomposite Biomaterial for 3D Printing of Personalized Matrices and Their Use in Bioreactors for Bioengineering Advanced Cell Culture Models.

Elisabetta Campodoni, Andrea Mazzoleni, Margherita Montanari, Gaia Vicinelli, Valentina Possetti, Antonio Inforzato, Ivan Martin, Manuele G Muraro, Monica Sandri

Abstract read
In one paragraph

Article in ACS applied materials & interfaces, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Elisabetta CampodoniInstitute of Science, Technology and Sustainability for Ceramics (ISSMC)─National Research Council (CNR), Faenza, Ravenna 48018, Italy.ORCID 0000-0001-8931-2921
Andrea MazzoleniDepartment of Biomedical Engineering, University of Basel, Basel CH-4001, Switzerland.
Margherita MontanariInstitute of Science, Technology and Sustainability for Ceramics (ISSMC)─National Research Council (CNR), Faenza, Ravenna 48018, Italy.
Gaia VicinelliInstitute of Science, Technology and Sustainability for Ceramics (ISSMC)─National Research Council (CNR), Faenza, Ravenna 48018, Italy.ORCID 0009-0000-9229-7996
Valentina PossettiDepartment of Biomedical Sciences, Humanitas University, Pieve Emanuele 20072, Italy.
Antonio InforzatoDepartment of Biomedical Sciences, Humanitas University, Pieve Emanuele 20072, Italy.
Ivan MartinDepartment of Biomedical Engineering, University of Basel, Basel CH-4001, Switzerland.ORCID 0000-0001-6493-0432
Manuele G MuraroTissue Engineering, Department of Biomedicine, University of Basel and University Hospital Basel, Basel CH-4001, Switzerland.ORCID 0000-0002-4590-1916
Monica SandriInstitute of Science, Technology and Sustainability for Ceramics (ISSMC)─National Research Council (CNR), Faenza, Ravenna 48018, Italy.ORCID 0000-0001-5782-3137

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Printing technology is a leading strategy for creating customized 3D matrices for tissue engineering. Our study developed an injectable nanocomposite hydrogel (bHAGel) for high-fidelity 3D extrusion printing composed of gelatin (Gel) and magnesium-doped biomimetic hydroxyapatite (bHA) particles that mimics a bone extracellular matrix. bHA particles, synthesized through a bioinspired mineralization process, acted as multifunctional additives, modulating rheology for printability, ensuring homogeneous phase distribution, enabling excellent model fidelity, and providing osteoinductive cues. The optimized hydrogel formulation enables the fabrication of porous scaffolds with interconnected macro- and microporosity via extrusion-based printing and freeze-drying. This key feature promoted cell infiltration and nutrient diffusion during tissue engineering procedures. Biological validation involves tailoring 3D scaffolds to fit a perfusion bioreactor chamber supporting seamless handling, seeding, and long-term culturing without scaffold removal or repositioning. Dynamic in vitro experiments with donor-derived human bone marrow stromal cells assessed the constructs' stability, ability to maintain geometry and perfusability, cytocompatibility and osteoconductivity, as well as robust osteogenic differentiation over 28 days. A more complex dynamic coculture model further demonstrated that the scaffold supports osteoclastogenesis under physiological, osteoblast-mediated conditions. Altogether, bHAGel scaffolds provided a customizable, bioactive platform suitable for engineering bone-mimetic organoids under dynamic conditions. Their modularity and biological relevance could be exploited in bone regeneration, disease modeling, and drug testing.

Indexed as

Biocompatible MaterialsBioreactorsNanocompositesPrinting, Three-DimensionalDurapatiteGelatinHumansHydrogelsMesenchymal Stem CellsOsteogenesisTissue EngineeringTissue ScaffoldsBiocompatible MaterialsDurapatiteGelatinHydrogels3D printingbone organoidsbone tissue regenerationhybrid hydroxyapatiteinjectable biomaterialsosteogenic differentiationperfusion bioreactor

Identifiers

PMID41355737
PMCPMC12723638

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.